Welcome to the e-CCO Library!

P271: Epidemiological characteristics and factors associated with ulcerative proctitis progression
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Dimitriu*1, S. Necula1, B. Cotruta1, L. Gheorghe1, C. S. Pop2

Created: Friday, 22 February 2019, 9:49 AM
P271: Evolving Targets in Ulcerative colitis: Defining Disease Clearance in the VARSITY Study
Year: 2021
Source: ECCO'21 Virtual
Authors: Danese, S.(1);Schreiber, S.(2);Loftus Jr., E.(3);Colombel, J.F.(4);Peyrin-Biroulet, L.(5);Agboton, C.(6);Lindner, D.(6);Lirio, R.(7);Sands, B.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P271: Fecal calprotectin at diagnosis is associated with oral steroid use first year of Inflammatory Bowel Disease.
Year: 2022
Source: ECCO'22
Authors: Strande, V.(1,2);Småstuen, M.C.(3,4);Huppertz-Hauss, G.(5);Perminow, G.(6);Henriksen, M.(7);Bengtson, M.B.(8);Høie, O.(9);Ricanek, P.(10);Opheim, R.(3,11);Cetinkaya, R.B.(12);Torp, R.(13);Vatn, S.(1,10);Aabrekk, T.B.(8);Detlie, T.E.(1,10);Hovde, Ø.(14,15);Høivik, M.L.(3,15);Kristensen, V.A.(2,3);
Created: Friday, 11 February 2022, 3:52 PM
P271: Predictive factors of a clinical severe course of Crohn’s disease: A monocentric study
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Agar*, L. Hamzaoui, S. Jardak, M. Medhioub, A. Khsiba, M.M. Azzouz

Created: Thursday, 21 February 2019, 9:14 AM
P271: Role of magnetic resonance in imaging of mesentery in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Surowiecka-Pastewka*1,2, M. Frączek3,4, J. Walecki3,4, M. Durlik1,2

Created: Friday, 22 February 2019, 9:41 AM
P271: Variability in histologic activity of paired same-segment biopsies in Crohn's disease dictates multiple biopsies needed to accurately evaluate histological status
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lenfant, M.(1,2)*;Vermeire, S.(1,2);Sabino, J.(1,2);Ferrante, M.(1,2);Verstockt, B.(1,2);De Hertogh, G.(3);
Created: Friday, 14 July 2023, 11:05 AM
P272 Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V.T.F. Cheung1, T. Gupta1, A. Olsson-Brown2, S. Subramanian3, S.C. Sasson1, J. Heseltine2, E. Fryer4, E. Collantes4, J.J. Sacco2, M. Pirmohamed5, A. Simmons1, P. Klenerman1, B.P. Fairfax6, M.J. Payne6, M.R. Middleton6, O. Brain1

Created: Thursday, 30 January 2020, 10:12 AM
P272: Azathioprine drug monitoring and faecal calprotectin levels in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Keil*1, L. Püschel1, A. Otte2, M. P. Manns1, O. Bachmann1

Created: Friday, 22 February 2019, 9:49 AM
P272: Developing a novel medication adherence index to determine reasons for nonadherence in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Zand*1, A. Nguyen1, Z. Stokes1, C. Reynolds1, M. Dimitrova1, J. Sauk1, D. Hommes1

Created: Friday, 22 February 2019, 9:41 AM
P272: Faecal calprotectin and magnetic resonance imaging are highly accurate to detect endoscopic postoperative recurrence in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Baillet P.1, Cadiot G.2, Goutte M.3,4, Goutorbe F.3,5, Allimant C.3, Reymond M.3, Obritin H.3, Bommelaer G.3,4, Pereira B.6, Hordonneau C.1, Buisson A.*3,4

Created: Wednesday, 20 February 2019, 10:36 AM
P272: Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in Korea
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y.M. Park1*, C.K. Lee1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1

Created: Thursday, 21 February 2019, 9:14 AM
P272: Psychological burden in newly diagnosed IBD patients: Differences between Crohn's Disease and Ulcerative Colitis in early IBD
Year: 2022
Source: ECCO'22
Authors: Bernabeu, P.(1);Cameo, J.I.(2);Gutiérrez, A.(2);García, G.(3);García, M.F.(4);Aguas, M.(5);Belen, O.(2);Zapater, P.(6);Cabezos, P.(1);Andreu, A.(1);Jover, R.(2);van-der Hofstadt , C.(1);Ruiz, M.T.(7);Sempere, L.(2);
Created: Friday, 11 February 2022, 3:52 PM
P272: Reduced delay in diagnosis of Crohn's disease in patients presenting with perianal disease: results of a retrospective cohort study at a non-academic, IBD-expert centre in the Netherlands
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Munster, L.(1)*;de Groof, E.J.(1);van Dieren, S.(2);Mundt, M.W.(3);D'Haens, G.R.A.M.(4);Bemelman, W.A.(5);Buskens, C.J.(5);van der Bilt, J.D.W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P272: Tofacitinib as salvage therapy for patients hospitalized with refractory severe active ulcerative colitis: a GETAID multicenter prospective/retrospective cohort
Year: 2021
Source: ECCO'21 Virtual
Authors: Uzzan, M.(1);Bresteau, C.(2);Laharie, D.(3);Stefanescu, C.(4);Carbonnel, F.(2);Serrero, M.(5);Viennot, S.(6);Nachury, M.(7);Amiot, A.(8);Altwegg, R.(9);Picon, L.(10);Nahon, S.(11);Vuitton, L.(12);Ah Soune, P.(13);Kirchgesner, J.(14);Peyrin-Biroulet, L.(15);Bouhnik, Y.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P273 Point-of-care bowel ultrasound for detecting ileocolonic inflammation in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Allocca1, G. Fiorino1, F. Furfaro1, A. Zilli1, D. Gilardi1, S. Radice1, L. Peyrin-Biroulet2, S. Danese1

Created: Thursday, 30 January 2020, 10:12 AM
P273: Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST study
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Panes1*, W.J. Sandborn2, E.V. Loftus Jr.3, G. Van Assche4, S. Ghosh5, Q. Zhou6, S. Goteti6, J.V. Enejosa6, A.L. Pangan6, A.P. Lacerda6

Created: Thursday, 21 February 2019, 9:14 AM
P273: Inflammatory Bowel Disease and COVID-19 vaccine
Year: 2022
Source: ECCO'22
Authors: Zahra Bianco , E.(1);Tabone , T.(1);Cassar , P.(2);Agius , D.(2);Zammit , D.(2);Vella Baldacchino , A.(1);Scicluna , C.(1);Gatt , K.(1);Ciantar , M.(2);Montebello , B.(2);Ellul , P.(1);Sciberras , M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P273: Investigations of the characteristics and efficacy of anti-TNFα agents for optimising treatment in paediatric patients with new-onset Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Yokoyama*1, K. Watanabe1, K. Kojima2, R. Koshiba2, K. Fujimoto2, T. Sato1, M. Kawai2, K. Kamikozuru2, T. Takagawa2, T. Miyazaki2, N. Hida2, S. Nakamura2

Created: Friday, 22 February 2019, 9:41 AM
P273: Prediction of treatment response in Crohn's disease patients using contrast enhanced ultrasound: a pilot study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zezos P.*1, Atri M.2, Zittan E.3, Nazarian A.4, Steinhart A.H.1, Silverberg M.S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P273: Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H.-S. Lee*1, H. J. Lee1, H. Seo2, M. Seo2, E. M. Song2, S. W. Hwang2, S. H. Park2, D.-H. Yang2, K.-J. Kim2, B. D. Ye2, J.-S. Byeon2, S.-J. Myung2, S.-K. Yang2

Created: Friday, 22 February 2019, 9:49 AM